- Home
- BGLC vs STRR Comparison
BGLC vs STRR Comparison
Compare BGLC & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- STRR
- Stock Information
- Founded
- BGLC 2017
- STRR 1985
- Country
- BGLC Malaysia
- STRR United States
- Employees
- BGLC N/A
- STRR N/A
- Industry
- BGLC Medical Specialities
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BGLC Health Care
- STRR Health Care
- Exchange
- BGLC Nasdaq
- STRR Nasdaq
- Market Cap
- BGLC 5.8M
- STRR 6.3M
- IPO Year
- BGLC N/A
- STRR N/A
- Fundamental
- Price
- BGLC $2.67
- STRR $2.49
- Analyst Decision
- BGLC
- STRR
- Analyst Count
- BGLC 0
- STRR 0
- Target Price
- BGLC N/A
- STRR N/A
- AVG Volume (30 Days)
- BGLC 1.6M
- STRR 19.0K
- Earning Date
- BGLC 05-23-2025
- STRR 05-14-2025
- Dividend Yield
- BGLC N/A
- STRR N/A
- EPS Growth
- BGLC N/A
- STRR N/A
- EPS
- BGLC N/A
- STRR N/A
- Revenue
- BGLC $9,510,646.00
- STRR $53,359,000.00
- Revenue This Year
- BGLC N/A
- STRR $43.37
- Revenue Next Year
- BGLC N/A
- STRR $23.60
- P/E Ratio
- BGLC N/A
- STRR N/A
- Revenue Growth
- BGLC N/A
- STRR 16.54
- 52 Week Low
- BGLC $2.01
- STRR $1.72
- 52 Week High
- BGLC $8.40
- STRR $5.35
- Technical
- Relative Strength Index (RSI)
- BGLC 46.93
- STRR 66.99
- Support Level
- BGLC $2.57
- STRR $2.14
- Resistance Level
- BGLC $2.76
- STRR $2.14
- Average True Range (ATR)
- BGLC 0.21
- STRR 0.23
- MACD
- BGLC 0.00
- STRR 0.05
- Stochastic Oscillator
- BGLC 20.24
- STRR 85.39
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.